Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 19, 2018

Primary Completion Date

November 22, 2019

Study Completion Date

March 25, 2021

Conditions

Type2 Diabetes

Interventions

DRUG

IDegLira

A single administration of IDegLira, dose depending on glicaemic control, in place of any pre-existing hipoglycaemic therapeutic scheme

Trial Locations (1)

Stefano Rizza, Roma

All Listed Sponsors

lead

Stefano Rizza

OTHER

NCT04190160 - Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira) | Biotech Hunter | Biotech Hunter